Check-Cap Ltd. (MBAI)
| Market Cap | 10.13M +158.4% |
| Revenue (ttm) | n/a |
| Net Income | 4.14M |
| EPS | 0.66 |
| Shares Out | 7.73M |
| PE Ratio | 2.12 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 89,717 |
| Open | 1.370 |
| Previous Close | 1.410 |
| Day's Range | 1.250 - 1.400 |
| 52-Week Range | 0.600 - 3.920 |
| Beta | 0.82 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |
About MBAI
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Financial Performance
Financial StatementsNews
Check-Cap Announces Reverse Share Split
ISFIYA, Israel, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (“Check-Cap” or the “Company”) (NASDAQ: MBAI) today announced a 1-for-7 reverse share split (the “Reverse Share Split”) of the Company'...
Check-Cap: MBody AI Takes Autonomous Services Outdoors, Expanding Addressable Market
Nasdaq-listed Check-Cap (NASDAQ: MBAI): MBody AI secures exclusive U.S. rights to outdoor cleaning robots in gaming and hospitality across six states. Nasdaq-listed Check-Cap (NASDAQ: MBAI): MBody AI ...
Check-Cap (MBAI) Sets Eight-Week Target for MBody AI Merger
Check-Cap Ltd. (NASDAQ: MBAI) has publicly filed its Form F-1 and now expects its merger with MBody AI Corp. to close within the next eight weeks Check-Cap Ltd. (NASDAQ: MBAI) has publicly filed its F...
Check-Cap files to sell ordinary shares, no amount given
Northland Capital Markets is acting as manger for the offering.
Check-Cap Registration statement: Registration filing
Check-Cap filed a registration statement on July 24, 2026, providing details about a securities offering with the SEC.
Check-Cap: MBody AI Advances Its Robot Fleet Operating System with Multi-Robot Control
ISFIYA, Israel and LAS VEGAS, July 16, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (“Check-Cap” or the “Company”) (NASDAQ: MBAI) today announced that its merger partner, MBody AI Corp. (“MBody AI”), has a...
Check-Cap: MBody AI Brings AI Robotics to Buyers Edge Platform Operators, Manufacturers and Distributors
Check-Cap ($MBAI): MBody AI signed a referral/channel deal with Buyers Edge, expanding access to ~286,000 operator, manufacturer & distributor locations.
Check-Cap Transcript: Planet MicroCap Las Vegas 2026
Robotics software integration is rapidly transforming labor-intensive industries, driven by labor shortages and hardware commoditization. The orchestration platform enables large clients to automate operations, reduce costs, and improve efficiency, with proven results in hospitality and healthcare.
Check-Cap Annual report: Q4 2025
Check-Cap has published its Q4 2025 annual report on April 27, 2026.
Check-Cap Registration statement: Registration Filing
Check-Cap filed a registration statement on February 2, 2026, providing details about a securities offering with the SEC.
Check-Cap Registration statement: Registration Filing
Check-Cap filed a registration statement on January 30, 2026, providing details about a securities offering with the SEC.
MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company
Nasdaq-listed AI company gains overwhelming shareholder support for its transformational merger, positioning MBody AI ($CHEK) as a hardware-agnostic embodied intelligence leader ready to scale enterpr...
MBody AI ($CHEK) Expands Global Leadership in Embodied AI With Major Wins
MBody AI ($CHEK) continues scaling its hardware-agnostic MBody AI Orchestrator(TM) platform across global enterprise deployments. Las Vegas, Nevada and Isfiya, Isreal--(Newsfile Corp. - November 10, 2...
RETRANSMISSION: Check-Cap and MBody AI Advance Toward Closing Transformational Merger
Shareholders gain exclusive early access to a market-leading embodied AI company driving global growth, innovation, and long-term value creation. Isfiya, Israel--(Newsfile Corp. - November 6, 2025) - ...
Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders
Company Has Suspended Calls Since the Second Quarter of 2024 to Avoid Facing the Music for Board's and Management Team's Destruction of 99% of Stock's Value, Costing Shareholders $1 Billion Conferenc...
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders
TORONTO , May 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management In...
Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction
Believes Board Change is Urgently Needed: Under the Current Board and Management, MediPharm Stock Price is Down More Than 99%, Costing Shareholders Nearly $1 Billion MediPharm's Board Cannot be Truste...
Check-Cap Annual report: Q4 2023
Check-Cap has published its Q4 2023 annual report on May 15, 2024.
Check-Cap Earnings release: Q4 2023
Check-Cap released its Q4 2023 earnings on May 15, 2024, summarizing the period's financial results.
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement
Proposed business combination to create a North American technology company with an AI-driven fintech marketplace. Combined company to apply for listing on Nasdaq and TSX TORONTO , March 25, 2024 /PRN...
SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD
TORONTO , Dec. 22, 2023 /PRNewswire/ - Symetryx Corporation ("Symetryx"), a Canadian venture company, is pleased to announce that the shareholders of Check-Cap Ltd. (NASDAQ: CHEK) voted overwhelmingly...
CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL
SYMETRYX RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER SYMETRYX RECOMMENDS VOTING FOR THEIR QUALIFIED INDEPENDENT BOARD NOMINEES TIME IS SHORT - THE VOTE DEADLINE IS 11:59 pm EST THURSDAY DECEM...
CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES
TORONTO , Dec. 8, 2023 /PRNewswire/ - Further to its news release of November 28, 2023, Symetryx continues to urge its fellow Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) shareholders to VOTE AGAINST ...
CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES
TORONTO , Dec. 5, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") once again encourages our fellow shareholders of Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) to review the news release i...
Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting
Recommends Fellow Shareholders Vote AGAINST Keystone Transaction & the Check-Cap Board Nominees - Further Recommends a Vote FOR the Symetryx Slate of Director Candidates Cites Unrealistic and Aggressi...